Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Non-inferiority Study Comparing Point-of-care Produced CAR T-cell to Commercial CAR T-cells in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma

NCT05641428 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05641428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05641428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Non-inferiority Study Comparing Point-of-care Produced CAR T-cell to Commercial CAR T-cells in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma
Lead sponsor
University Medical Center Groningen
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 18, 2022
Completion date
September 30, 2028
Enrollment
340 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

dlbcl - diffuse large b cell lymphoma, nhl